What are the recommended starting dose, titration schedule, and maintenance dosing frequency for primidone in adults and children?

Primidone Dosage and Frequency

For adults and children over 8 years, start primidone at 100-125 mg at bedtime and titrate gradually over 10 days to a maintenance dose of 250 mg three times daily (750 mg/day), with a maximum of 500 mg four times daily (2000 mg/day) if needed. 1

Adult and Pediatric Dosing (≥8 Years)

Initial Titration Schedule

The FDA-approved titration schedule minimizes acute toxicity while achieving therapeutic levels 1:

• Days 1-3: 100-125 mg at bedtime
• Days 4-6: 100-125 mg twice daily
• Days 7-9: 100-125 mg three times daily
• Day 10 onward: 250 mg three times daily (maintenance)

Maintenance Dosing

• Standard maintenance: 250 mg three times daily (750 mg/day) or four times daily (1000 mg/day)
• Maximum dose: 500 mg four times daily (2000 mg/day) if required
• Therapeutic serum level: 5-12 mcg/mL 1

Important clinical note: Research demonstrates that lower maintenance doses (250 mg/day) can be equally effective as higher doses (750 mg/day) for essential tremor, with significantly fewer side effects and better tolerability 2. However, for seizure control, the standard FDA dosing should be followed.

Pediatric Dosing (Under 8 Years)

Initial Titration Schedule

• Days 1-3: 50 mg at bedtime
• Days 4-6: 50 mg twice daily
• Days 7-9: 100 mg twice daily
• Day 10 onward: 125-250 mg three times daily (maintenance)

Maintenance Dosing

• Weight-based: 10-25 mg/kg/day in divided doses
• Typical range: 125-250 mg three times daily 1

For neonates and young infants with refractory seizures, a dose of 25 mg/kg/day in 3 divided doses has been shown effective, with seizure control typically achieved within 3-5 days when primidone levels exceed 10 mcg/mL 3.

Critical Prescribing Considerations

Acute Toxicity Management

The first 48 hours are critical. Acute side effects (nausea, vomiting, dizziness, sedation) occur in approximately one-third of patients and are related to initial primidone exposure rather than its metabolites 4, 5. These effects typically:

• Peak within the first 2 doses
• Are dose-dependent
• May cause treatment discontinuation in up to 15-26% of patients at higher starting doses 2

Cross-Tolerance Strategy

For patients at high risk of acute toxicity, consider phenobarbital pretreatment. Loading with phenobarbital for several days before initiating primidone at 500 mg/day can minimize acute adverse events through cross-tolerance, with 87% of patients tolerating introduction with minimal symptoms 6. This approach allows starting at higher doses when clinically necessary.

Transitioning from Other Anticonvulsants

When converting from other antiepileptic drugs:

• Start primidone at 100-125 mg at bedtime
• Gradually increase primidone while simultaneously tapering the other medication
• Complete transition should take at least 2 weeks 1

Monitoring Requirements

• Serum levels should be checked for optimal dosage adjustment, targeting 5-12 mcg/mL
• Both primidone and phenobarbital levels should be monitored, as primidone is metabolized to phenobarbital (active metabolite) 7
• In neonates, seizure control correlates best with primidone and phenylethylmalonamide levels rather than phenobarbital levels 3

Common Pitfalls to Avoid

1. Starting too high: Initiating at doses >125 mg significantly increases acute toxicity risk without improving long-term efficacy
2. Rapid titration: Increasing doses faster than the recommended schedule increases discontinuation rates
3. Ignoring metabolite levels: Phenobarbital accumulation over time may reduce efficacy and increase side effects 5
4. Inadequate trial duration: Auto-induction of metabolic systems occurs over weeks; levels and efficacy may change during the first month 3